03Feb/14

Boston Scientific Receives FDA Approval For Promus PREMIER™ Everolimus … – Angioplasty.Org


Angioplasty.Org

Boston Scientific Receives FDA Approval For Promus PREMIER™ Everolimus
Angioplasty.Org
November 25, 2013 — Natick, Massachusetts — Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the Promus PREMIER™